Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone + Loratadine vs Mometasone + Montelukast in Allergic Rhinitis
NCT07532993Phase 4Not yet recruiting
- Sponsor
- Liaquat National Hospital & Medical College
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mometasone furoate nasal spray, loratadine, montelukast in allergic rhinitis (AR), sponsored by Liaquat National Hospital & Medical College. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
mometasone furoate nasal sprayloratadinemontelukast
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07532993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532993.